Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer

4 Jun 2021

Abstract excerpt

SHMT2 was overexpressed in many tumors, however, the role of SHMT2 in bladder cancer (BLCA) remains unclear. We first analyzed the expression pattern of SHMT2 in BLCA using the TNMplot, Oncomine, the Cancer Genome Atlas (TCGA), and the Gene Expression Omnibus (GEO) databases. Next, the association between SHMT2 expression and overall survival (OS)/disease-free survival (DFS) in BLCA patients were analyzed using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34149818
DOI: 10.3389/fgene.2021.682856

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder CancerPMID 34149818Read ↗

Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancerSemantic proximity Read ↗

RRM2 Is a Putative Biomarker and Promotes Bladder Cancer Progression via PI3K/AKT/mTOR PathwaySemantic proximity Read ↗

Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancerSemantic proximity Read ↗

Silencing SHMT2 Inhibits the Progression of Oral Squamous Cell Carcinoma Through Cell Cycle RegulationSemantic proximity Read ↗

High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancerSemantic proximity Read ↗

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating With Immune Infiltrates in Lung AdenocarcinomaSemantic proximity Read ↗

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltrationSemantic proximity Read ↗

LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder CancerSemantic proximity Read ↗

EZH2 in Bladder Cancer, a Promising Therapeutic TargetSemantic proximity Read ↗

Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translationSemantic proximity Read ↗

5hmC and TET2 Dysregulation in Bladder Cancer: Diagnostic and Prognostic ImplicationsSemantic proximity Read ↗

STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.